{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:09:44Z","timestamp":1790770184417,"version":"4.1.0"},"reference-count":100,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,8,14]]},"DOI":"10.18632\/oncotarget.4574","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T04:50:54Z","timestamp":1442292654000},"page":"19381-19392","source":"Crossref","is-referenced-by-count":55,"title":["The MYC<i>\/miR-17-92<\/i> axis in lymphoproliferative disorders: A common pathway with therapeutic potential"],"prefix":"10.18632","volume":"6","author":[{"given":"Michele","family":"Dal Bo","sequence":"first","affiliation":[{"name":"Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano PN, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bomben","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano PN, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Clinic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano PN, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2353\/ajpath.2009.080794","article-title":"MiRNAs and cancer","volume":"174","author":"Croce","year":"2009","journal-title":"Am J Pathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tig.2006.01.003","article-title":"Genomics of microRNA","volume":"22","author":"Nam","year":"2006","journal-title":"Trends Genet"},{"key":"3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-4598-6-60","article-title":"OncomiRs: the discovery and progress of microRNAs in cancers","volume":"6","author":"Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1463-1326.2007.00775.x","article-title":"microRNAs and the regulation of glucose and lipid metabolism","volume":"9","author":"Stoffel","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molcel.2005.09.012","article-title":"MicroRNAs and viral infection","volume":"20","author":"Ganem","year":"2005","journal-title":"Mol Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1515\/BC.2008.026","article-title":"Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs","volume":"389","author":"Regazzi","year":"2008","journal-title":"Biol Chem"},{"key":"9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2008.12.027","article-title":"MicroRNA control in the immune system: basic principles","volume":"136","author":"Rajewsky","year":"2009","journal-title":"Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Negrini","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Croce","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"O'brien-Jenkins","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Croce","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","article-title":"Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma","volume":"64","author":"Seto","year":"2004","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1158\/0008-5472.CAN-08-1768","article-title":"Emerging role of miR-106b-25\/miR-17-92 clusters in the control of transforming growth factor beta signaling","volume":"68","author":"Croce","year":"2008","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1158\/0008-5472.CAN-10-2412","article-title":"The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors","volume":"70","author":"Thomas-Tikhonenko","year":"2010","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"Hammond","year":"2005","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"Mendell","year":"2005","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters","volume":"132","author":"Jacks","year":"2008","journal-title":"Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","article-title":"miRiad roles for the miR-17-92 cluster in development and disease","volume":"133","author":"Mendell","year":"2008","journal-title":"Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Lanza","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/leu.2012.44","article-title":"The miR-17 approximately 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes","volume":"26","author":"Efremov","year":"2012","journal-title":"Leukemia"},{"key":"23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Horvitz","year":"2005","journal-title":"Nature"},{"key":"24","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","article-title":"MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas","volume":"69","author":"Ott","year":"2009","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/modpathol.3800326","article-title":"Gains of 13q are correlated with a poor prognosis in liposarcoma","volume":"18","author":"Taubert","year":"2005","journal-title":"Mod Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","article-title":"A microRNA cluster as a target of genomic amplification in malignant lymphoma","volume":"19","author":"Seto","year":"2005","journal-title":"Leukemia"},{"key":"27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Rigoutsos","year":"2013","journal-title":"Cell Death Differ"},{"key":"28","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biocel.2010.03.004","article-title":"miR-17-92, a cluster of miRNAs in the midst of the cancer network","volume":"42","author":"He","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"29","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/emboj.2013.178","article-title":"MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways","volume":"32","author":"Xiao","year":"2013","journal-title":"EMBO J"},{"key":"30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijc.23153","article-title":"MYCN regulates oncogenic MicroRNAs in neuroblastoma","volume":"122","author":"Eilers","year":"2008","journal-title":"Int J Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.molcel.2010.11.038","article-title":"The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma","volume":"40","author":"Zollo","year":"2010","journal-title":"Mol Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1074\/jbc.C600252200","article-title":"Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors","volume":"282","author":"Hammond","year":"2007","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"e46799","DOI":"10.1371\/journal.pone.0046799","article-title":"Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in friend erythroleukemia","volume":"7","author":"Guyot","year":"2012","journal-title":"PLoS One"},{"key":"34","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","article-title":"Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway","volume":"104","author":"Huber","year":"2009","journal-title":"Circ Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/emboj.2009.214","article-title":"Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis","volume":"28","author":"Sun","year":"2009","journal-title":"EMBO J"},{"key":"36","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.0914900107","article-title":"Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia","volume":"107","author":"He","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"37","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/emboj.2011.317","article-title":"Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation","volume":"30","author":"Stopka","year":"2011","journal-title":"EMBO J"},{"key":"38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng.858","article-title":"A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)","volume":"43","author":"Socci","year":"2011","journal-title":"Nat Genet"},{"key":"39","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","article-title":"Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas","volume":"23","author":"Ventura","year":"2009","journal-title":"Genes Dev"},{"key":"40","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","article-title":"miR-19 is a key oncogenic component of miR-17-92","volume":"23","author":"He","year":"2009","journal-title":"Genes Dev"},{"key":"41","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.7554\/eLife.00822","article-title":"A component of the miR-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis","volume":"2","author":"Goga","year":"2013","journal-title":"Elife"},{"key":"42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ccr.2014.06.014","article-title":"MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state","volume":"26","author":"Felsher","year":"2014","journal-title":"Cancer Cell"},{"key":"43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Rajewsky","year":"2008","journal-title":"Nat Immunol"},{"key":"44","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood-2011-09-378687","article-title":"The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice","volume":"119","author":"Ben-David","year":"2012","journal-title":"Blood"},{"key":"45","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1315365110","article-title":"B-cell malignancies in microRNA Emu-miR-17~92 transgenic mice","volume":"110","author":"Croce","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.leukres.2014.12.002","article-title":"Limited miR-17-92 overexpression drives hematologic malignancies","volume":"39","author":"Hernando","year":"2015","journal-title":"Leuk Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/gb-2008-9-8-r127","article-title":"The miR-17-5p microRNA is a key regulator of the G1\/S phase cell cycle transition","volume":"9","author":"Grimmond","year":"2008","journal-title":"Genome Biol"},{"key":"48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/387422a0","article-title":"Myc and Ras collaborate in inducing accumulation of active cyclin E\/Cdk2 and E2F","volume":"387","author":"Nevins","year":"1997","journal-title":"Nature"},{"key":"49","doi-asserted-by":"crossref","first-page":"D121","DOI":"10.2741\/A501","article-title":"Role of pRB dephosphorylation in cell cycle regulation","volume":"5","author":"Ludlow","year":"2000","journal-title":"Front Biosci"},{"key":"50","doi-asserted-by":"crossref","first-page":"e16138","DOI":"10.1371\/journal.pone.0016138","article-title":"MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC","volume":"6","author":"Wernet","year":"2011","journal-title":"PLoS One"},{"key":"51","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1074\/jbc.M608939200","article-title":"An E2F\/miR-20a autoregulatory feedback loop","volume":"282","author":"Chartrand","year":"2007","journal-title":"J Biol Chem"},{"key":"52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200801079","article-title":"A cyclin D1\/microRNA 17\/20 regulatory feedback loop in control of breast cancer cell proliferation","volume":"182","author":"Pestell","year":"2008","journal-title":"J Cell Biol"},{"key":"53","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1371\/journal.pgen.0030146","article-title":"\u201cMyc'ed messages\u201d: myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron","volume":"3","author":"Legesse-Miller","year":"2007","journal-title":"PLoS Genet"},{"key":"54","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2012-12-473090","article-title":"The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop","volume":"122","author":"Thomas-Tikhonenko","year":"2013","journal-title":"Blood"},{"key":"55","doi-asserted-by":"crossref","DOI":"10.1097\/MOH.0b013e3283623d7f","article-title":"The genetic basis of diffuse large B-cell lymphoma","author":"Pasqualucci","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.20946","article-title":"Neoplastic MiR-17~92 deregulation at a DNA fragility motif (SIDD)","volume":"51","author":"Macleod","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"57","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma","volume":"121","author":"Hatton","year":"2007","journal-title":"Int J Cancer"},{"key":"58","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Ott","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"59","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1349-7006.2007.00531.x","article-title":"Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development","volume":"98","author":"Seto","year":"2007","journal-title":"Cancer Sci"},{"key":"60","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Gascoyne","year":"2009","journal-title":"Blood"},{"key":"61","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2012-01-406033","article-title":"MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation","volume":"119","author":"Houlgatte","year":"2012","journal-title":"Blood"},{"key":"62","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Cogliatti","year":"2013","journal-title":"Blood"},{"key":"63","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/cncr.28899","article-title":"MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches","volume":"120","author":"Smith","year":"2014","journal-title":"Cancer"},{"key":"64","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Meyer","year":"2012","journal-title":"J Clin Oncol"},{"key":"65","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":"High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma","volume":"36","author":"Moller","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.10","article-title":"Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma","volume":"22","author":"Kluin","year":"2009","journal-title":"Mod Pathol"},{"key":"67","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nor107","article-title":"Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas","volume":"13","author":"Thiel","year":"2011","journal-title":"Neuro Oncol"},{"key":"68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11060-012-0908-2","article-title":"MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma","volume":"109","author":"Schroers","year":"2012","journal-title":"J Neurooncol"},{"key":"69","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Pinkus","year":"2005","journal-title":"Blood"},{"key":"70","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Hatton","year":"2009","journal-title":"J Cell Mol Med"},{"key":"71","article-title":"Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas","author":"Piris","year":"2009","journal-title":"Hematol Oncol"},{"key":"72","doi-asserted-by":"crossref","first-page":"e20781","DOI":"10.1371\/journal.pone.0020781","article-title":"Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas","volume":"6","author":"Martinez-Maza","year":"2011","journal-title":"PLoS One"},{"key":"73","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/leu.2011.305","article-title":"The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K\/AKT pathway activation","volume":"26","author":"Fu","year":"2012","journal-title":"Leukemia"},{"key":"74","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","article-title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","volume":"119","author":"Staudt","year":"2012","journal-title":"Blood"},{"key":"75","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM","volume":"24","author":"Seto","year":"2005","journal-title":"Oncogene"},{"key":"76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Yang","year":"2012","journal-title":"Nature"},{"key":"77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","article-title":"Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression","volume":"155","author":"Miles","year":"2011","journal-title":"Br J Haematol"},{"key":"78","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Trumper","year":"2010","journal-title":"Haematologica"},{"key":"79","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Dang","year":"2001","journal-title":"Oncogene"},{"key":"80","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.80.22.6922","article-title":"Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma","volume":"80","author":"Croce","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"81","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/j.1460-2075.1992.tb05409.x","article-title":"Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc","volume":"11","author":"Eick","year":"1992","journal-title":"EMBO J"},{"key":"82","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0092-8674(84)90227-7","article-title":"Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells","volume":"36","author":"Leder","year":"1984","journal-title":"Cell"},{"key":"83","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2008.377","article-title":"miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities","volume":"23","author":"Pospisilova","year":"2009","journal-title":"Leukemia"},{"key":"84","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Miyazono","year":"2009","journal-title":"Nature"},{"key":"85","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1073\/pnas.1019557108","article-title":"MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia","volume":"108","author":"Galas","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1097-2765(01)00284-2","article-title":"p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis","volume":"8","author":"Nakamura","year":"2001","journal-title":"Mol Cell"},{"key":"87","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/emboj.2008.85","article-title":"Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation","volume":"27","author":"Eilers","year":"2008","journal-title":"EMBO J"},{"key":"88","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1097-2765(00)00071-X","article-title":"E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control","volume":"6","author":"Rempel","year":"2000","journal-title":"Mol Cell"},{"key":"89","first-page":"2010","article-title":"SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases","author":"Naka","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"90","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1158\/0008-5472.CAN-03-1563","article-title":"B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia","volume":"65","author":"Zuzel","year":"2005","journal-title":"Cancer Res"},{"key":"91","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2004-05-1715","article-title":"ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia","volume":"105","author":"Kipps","year":"2005","journal-title":"Blood"},{"key":"92","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2006-03-011759","article-title":"ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells","volume":"109","author":"Efremov","year":"2007","journal-title":"Blood"},{"key":"93","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Stevenson","year":"2007","journal-title":"Blood"},{"key":"94","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/leu.2011.299","article-title":"Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b\/miR-99a\/let-7c and miR-17-92 in chronic lymphocytic leukaemia","volume":"26","author":"Wagner","year":"2012","journal-title":"Leukemia"},{"key":"95","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat Rev Genet"},{"key":"96","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAswith \u2018antagomirs\u2019","volume":"438","author":"Stoffel","year":"2005","journal-title":"Nature"},{"key":"97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Kauppinen","year":"2012","journal-title":"Silence"},{"key":"98","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Kauppinen","year":"2013","journal-title":"N Engl J Med"},{"key":"99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2014.08.015","article-title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","volume":"111","author":"Janssen","year":"2014","journal-title":"Antiviral Res"},{"key":"100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13045-014-0079-z","article-title":"Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia","volume":"7","author":"Bomben","year":"2014","journal-title":"J Hematol Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T13:00:15Z","timestamp":1589374815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":100,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,8,14]]}},"alternative-id":["4574","26305986"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4574","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}